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The concept of economic profit (EVA1) has proved successful in the field of corporate finance 
since its adoption by several U.S. and International companies over the past 25 years. Unlike 
accounting earnings, EVA is a measure of a company’s true earnings because it fully “accounts” 
for the costs of all forms of financing, including debt and equity.  In the EVA view, a company is 
not truly profitable unless it earns a return on capital that bests the opportunity cost of capital.  
That being said, the question that we address here is how to measure the economic profit of 
providers in the healthcare sector, which is largely comprised of Not-for-Profit organizations 
such as clinics, laboratories, and hospitals.2  
We’ll begin the EVA journey for healthcare providers by abstracting from the myriad of 
accounting adjustments that can be made to estimate EVA and instead look at how to estimate 
“basic” economic profit in both For Profit (the traditional realm for EVA application) and Not-
for-Profit settings. The financial goal here is twofold: (1) to illustrate the key ingredients of 
economic profit for healthcare providers without getting tangled up in a web of accounting 
adjustments and, (2) to illustrate the advantage of using economic profit over traditional 
accounting profit measures such as operating margins and net income.  
We’ll then discuss the concept of “disclosed” EVA for healthcare providers, which 
reflects income statement and balance sheet effects of several value-based accounting 
adjustments to economic profit. These EVA accounting adjustments include the traditional ones 
identified by Stewart3; such as the EVA treatment of research and development expenditures, 
inventory costing (LIFO/FIFO), lease expense, restructuring costs, and conversion from reported 
income taxes to cash operating taxes (For-Profit companies).   
In turn, we’ll examine unique EVA accounting adjustments for healthcare providers 
(applicable to both For-Profit and Not-for-Profit healthcare organizations). These include (1) 
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income statement adjustments for changes in net charity care (net uncompensated care) 
expenditures 4, medical training costs, and community wellness and prevention program costs, 
and (2) the corresponding EVA balance sheet adjustments which reflect the capitalization of 
provider-based intangibles as equity equivalents, particularly “net asset” or “fund equity” 
equivalents in the case of Not-for-Profit healthcare providers.5
 
BASIC EVA 
For-Profit Provider 
We’ll begin by estimating EVA in the traditional For-Profit setting. We can then make tax-
related adjustments to this framework that would apply to the predominance of healthcare 
providers in the Not-for-Profit sector of the economy. In this context, there are two basic 
ingredients to estimating EVA—namely, NOPAT, which stands for net operating profit after tax, 
and $WACC, which is the dollar cost of invested capital. We’ll start with NOPAT.  
In the absence of EVA accounting adjustments, a For-Profit provider’s net operating 
profit after tax can be expressed in terms of its tax-adjusted earnings before interest and taxes, 
EBIT, according to:6
 
    NOPAT = EBIT–Cash Taxes 
    =EBIT x (1-t) 
         = [R-COMS-SG&A-D] x (1-t) 
 
In this expression, EBIT x (1-t) is the provider’s NOPAT. This EVA term is a reflection of the 
provider’s earnings before interest and taxes, EBIT, less its unlevered business taxes.7  Likewise, 
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the terms, R, COMS, and SG&A in the NOPAT formulation refer to the provider’s Net Revenue, 
Cost of Medical Services, and Selling, General and Administrative Expenses, respectively. In 
principle, the depreciation term, D, should be a charge that reflects the economic obsolescence of 
the provider’s assets. In turn, the dollar cost of capital, $WACC, can be expressed as: 
 
    $WACC = WACC x C 
 
In this expression, WACC is the weighted-average cost of debt and equity capital (expressed as a 
required rate in decimal form), and C is the provider’s net operating capital. In turn, the weighted 
average capital cost, WACC, is given by: 
 
   WACC = After-tax Debt Cost x Debt Weight 
     + Equity Cost x Equity Weight 
 
Taken together, these developments show that a For Profit provider’s EVA can be expressed in 
basic terms as: 
 
    EVA = NOPAT - $WACC 
             = EBIT x (1-t) – WACC x C 
             = [R-COMS-SG&A-D] x (1-t) – WACC x C 
 
The basic EVA formula shows that a For Profit provider’s economic profit is equal to its 
net operating profit after tax less the dollar cost of all capital employed within the organization. 
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In the next section, we’ll look at a simple income statement and balance sheet for a hypothetical 
For-Profit provider to illustrate how to measure basic EVA. We’ll then look at the adjustments to 
basic EVA that need to be made in the Not-for-Profit setting. Along the way, we’ll discuss the 
ways to increase EVA to improve organization efficiency and to enhance organizational value. 
We’ll conclude our EVA journey by explaining the concept of “disclosed” EVA, which reflects 
both traditional and unique accounting adjustments that apply in both For Profit and Not-for-
Profit healthcare settings. 
 
“OK-HEALTH” Provider 
We’ll now illustrate how to measure basic EVA for a For-Profit provider called “OK Health.” 
The goal here is to see if OK Health is in fact “okay” from an economic profit perspective.8 
We’ll then explain the tax adjustments to basic EVA that are necessary if instead OK Health 
were a Not-for-Profit clinic, hospital, or laboratory. To begin, Exhibits 1 and 2 show the income 
statement and balance sheet respectively for OK Health at a point in time. 
 When viewing OK Health’s financial statements from an accounting perspective, it 
appears that it is a profitable healthcare provider. Based on the income statement shown in 
Exhibit 1, OK Health reports a positive gross margin, at 31.2% (39,000/125,000), and a positive 
operating margin, at 13.6% (17,000/125,000).9  As a For Profit provider, OK Health’s net 
income and operating earnings per share are also positive, at $8,213 and $1.31, respectively. In 
turn, with Stockholder’s Equity at $96,600 its return on equity (ROE) seems favorable, at 8.5% 
(8,213/96,600 x 100). Moreover, based on the “Dupont formula,” the provider’s ROE results 
from multiplying its return on assets, ROA at 5.4%, by the equity multiplier (Assets/Equity) of 
1.57.10
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OK Health’s Economic Profit 
 
To see if OK Health is truly a profitable healthcare provider—that is, a value creator in financial 
terms—we’ll first calculate the provider’s net operating profit after tax, NOPAT. Upon 
substituting the provider’s Net Revenue, Cost of Medical Services, Selling General and 
Administrative, and tax rate figures into the NOPAT formulation, we obtain:11
 
   NOPAT = [R-COMS-SG&A] x (1-t) 
         = [125,000-86,000-22,000] x (1-0.4) 
         = 17,000 x 0.6 = $10,200 
 
In order to measure OK Health’s dollar cost of capital, the manager needs to know something 
about (1) the after-tax cost of debt, (2) the cost of equity capital, and (3) the “target” debt weight, 
if any, in the capital structure, and (4) the dollar amount of capital employed in its healthcare 
organization.12 With respect to the first requirement, OK Health’s after-tax cost of debt can be 
estimated according to: 
   After-tax Debt Cost = Pre-tax Debt Cost x (1-t) 
              = 0.08 x (1-0.4) 
              = 0.048 or 4.8% 
 
In this expression, the pre-tax debt cost, at 8%, is taken as the provider’s average coupon rate on 
the balance sheet (for simplicity, we assume that the provider’s bonds are trading at par value). 
OK Health’s pre-tax borrowing cost of 8% can also be obtained by dividing the provider’s 
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interest expense, $3,312 (income statement), by the face value of its long term debt, at $41,400 
(balance sheet).  
 In turn, we’ll use the Capital Asset Pricing Model to estimate OK Health’s cost of 
equity.13 With a risk-free interest rate of 6.5%, a market-driven equity risk premium of 6%, and a 
common stock beta of 1.0, the provider’s (CAPM-based) cost of equity capital becomes: 14
 
   CAPM = Rf + MRP x Beta 
    = 0.065 + 0.06 x 1.0 
    = 0.125 or 12.5% 
 
Moreover, if we assume that OK Health’s “target” debt-to-capital ratio is 30%, the provider’s 
overall cost of capital can be measured according to: 
   WACC = After-tax Debt Cost x Debt Weight 
     +  Equity Cost x Equity Weight 
     = 0.048 x (0.3) + 0.125 x (0.7) 
     = 0.102 or 10.2% 
 
Repackaging the Balance Sheet 
With knowledge of OK Health’s operating capital it is possible to calculate the dollar cost of 
capital, $WACC.  In this context, it is helpful to recognize that the provider’s balance sheet can 
be “repackaged” in a way that shows the equivalency of its operating and financing capital. 
Exhibit 3 illustrates this result. 
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 Exhibit 3 shows that OK Health’s operating and financing capital is $138,000. The 
operating capital (left hand side of balance sheet) is equal to net working capital (excluding debt-
related short term accounts) plus net plant, property and equipment (as well as other operating 
assets). Likewise, in the absence of EVA accounting adjustments, the financing capital is just 
long-term debt (including short-term debt accounts, minority interest, and capitalized lease 
obligations, if any) plus stockholders’ equity (including both preferred and common equity). 
Hence, the provider’s overall dollar-cost of capital can be measured by applying the weighted 
average cost of capital, at 10.2%, to either the provider’s tangible operating capital or its 
equivalent financing sources of capital. Whatever side of the EVA balance sheet is chosen, OK 
Health’s dollar cost of capital is $14,076: 
   $WACC = WACC x C 
              = 0.102 x 138,000 
              = $14,076 
 
More importantly, since OK Health’s dollar cost of financing, $WACC, is higher than its net 
operating profit after tax, NOPAT, the healthcare provider has negative economic profit: 
 
   EVA = NOPAT - $WACC 
            = 10,200 - 14,076 
            = -$3,876 
 
Thus, while OK Health looks like a profitable healthcare producer from a traditional accounting 
perspective, the EVA insight reveals that the provider is a (potential15) value destroyer. This 
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happens because its operating profitability is not sufficient enough to cover the overall dollar 
cost of capital.  
 
OK Health’s Residual Return on Capital 
We can also show that OK Health has negative EVA because its underlying “residual (or 
surplus) return on capital”, RROC, is negative. This value wasting situation occurs when a 
provider’s after-tax return on capital, ROC, falls short of the weighted average capital cost, 
WACC. To illustrate this, simply define RROC as the provider’s EVA-to-Capital ratio. At -
2.8%, one sees that OK Health’s adverse surplus return on capital is caused by its negative 
economic profit: 
 
   RROC = EVA/Capital 
    = -3,876/138,000 
    = -0.028 or -2.8% 
 
Likewise, since EVA can be expressed as the provider’s initial capital, C, times the residual 
return on capital, RROC, the same result is obtained by focusing on the spread between the after-
tax return on capital, ROC, and the weighted average cost of debt and equity capital, WACC:16
 
   RROC = EVA/C 
    = [ROC - WACC] 
    = [0.074 - 0.102] = -0.028 
    = -0.028 or -2.8% 
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In this expression, ROC, at 7.4%, results from dividing NOPAT, $10,200, by the provider’s 
capital, $138,000. The WACC is the familiar cost of capital percentage of 10.2%. 
 
OK Health’s Interest Tax Subsidy 
When looking at OK Health as a For Profit provider, it is important to use its net operating profit 
after tax, NOPAT in the first step of the EVA calculation. This is because the dollar cost of 
capital (step two of the EVA calculation) already reflects the interest tax subsidy received on the 
provider’s outstanding debt obligations. By double counting this debt-induced tax subsidy, the 
manager or analyst would not only overestimate the provider’s operating profit, but he or she 
would also impart a positive bias in the provider’s organizational value (enterprise value in the 
traditional for-profit realm of corporate valuation). 
 To show the source of bias, it is helpful to note that the “levered” provider’s net operating 
profit after tax, LNOPAT, can be expressed in terms of the equivalent risk “unlevered” 
provider’s net operating profit, NOPAT,  plus a yearly interest tax subsidy. Looking at OK 
Health in this levered (with debt) and unlevered (without debt) context yields: 
 
   LNOPAT = NOPAT + t x Interest 
         = $10,200 + 0.4 x $3,312 
         = $10,200 + $1,325 
         = $11,525 
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In this expression, t x Interest (at $1,325), is the yearly interest tax subsidy that OK Health 
receives as a For-Profit levered provider, as opposed to a For-Profit debt-free provider. However, 
this same interest tax benefit is already reflected in the provider’s dollar cost capital cost through 
the reduced cost of corporate debt financing.   
 To show this, recall that OK Health’s after tax cost of debt was previously expressed as: 
   After-tax debt cost = Pre-tax debt cost x (1-t) 
            = 0.08 x (1-0.4) 
            = 0.048 or 4.8% 
 
In this formulation, the provider’s pre-tax cost of debt, 8%, is reduced by 320 basis points due to 
the tax benefit that OK Health receives from deductibility of its debt interest expense. Expressing 
this leverage-induced reduction in the For-Profit provider’s dollar cost of capital yields the same 
yearly interest tax benefit that is already reflected in the provider’s levered operating profit: 
 
   $WACC Tax Subsidy = t x [Pre-tax Debt Cost] x Debt 
             = 0.4 x [3,312/41,400] x 41,400 
              = $1,325 
 
 To avoid positive bias, OK Health’s economic profit must be calculated by first 
estimating what its net operating profit after tax, NOPAT, would be as an equivalent risk 
unlevered provider--namely, an “OK Health like” provider with no debt--and then subtracting 
the overall dollar cost of debt and equity capital from this unlevered NOPAT figure. 
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BASIC EVA 
Not-for-Profit Provider 
There are several issues that arise when measuring EVA in a Not-for-Profit setting. The first is 
obvious: NOPAT and $WACC must be stated on a pre-tax basis, which we’ll address shortly. A 
second and more fundamental issue arises in the interpretation of the pre-tax cost of debt and the 
cost of equity for Not-for-Profit providers. With respect to debt financing, the pre-tax cost of 
debt should be interpreted as the yield to maturity on an equivalent-risk, tax-exempt bond issued 
by a local, regional, or state healthcare authority.  
In the case of equity financing, we can interpret this cost as a cost of “fund” equity.17 
With that view, the opportunity cost of equity for a Not-for-Profit provider equals the “grossed 
up” equity cost of a For-Profit provider. This is due to the fact that CAPM (one measure of 
equity cost) is an after-tax rate and Not-for-Profits do not pay taxes (typically) on operating 
income. In principle, the pre-tax CAPM can be interpreted as a cost of fund equity because the 
perceived benefits from donor contributions (fund equity) can be viewed in financial terms as 
being worth what a charitable giver or donor could have earn on a similar risk portfolio of 
investment securities. The same opportunity cost concept applies in the case of retained earnings 
by Not-For-Profit organizations; as equity capital in For Profit and Not-for-Profit settings is not 
“free capital”. Also, another issue that arises when measuring EVA for Not-for-Profits involves 
“equity equivalents”. We’ll address unique equity equivalents for providers-such as the 
capitalized values of charity care (net), medical training costs, and community wellness and 
prevention programs costs-at a later point. 
There are of course tax adjustments to NOPAT and $WACC that must be made when 
estimating EVA in the Not-for-Profit setting. If, for example, we measure OK Health’s EVA on 
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a pretax basis-because (1) the healthcare manager wants to make a comparison of operating 
performance with a Not-for-Profit provider, or (2) because OK Health is actually a Not-for-Profit 
provider--then we need to estimate EVA components (NOPAT and $WACC) on a pre-tax basis. 
In this context, the healthcare provider’s net operating profit before taxes, NOPBT, would be 
used in conjunction with a pre-tax dollar cost of capital.  
To see how this works, we can express OK Health’s net operating profit before tax as: 
 
NOPBT = NOPAT/(1-t) 
                       = EBIT x (1-t)/(1-t) 
                      = EBIT = $17,000 
 
In turn, the provider’s weighted average cost of capital must be expressed on a pre-tax basis. The 
only complication here is that the after-tax cost of equity needs to be “grossed up” by one minus 
the (marginal) corporate tax rate to convert it to a pre-tax fund-equity rate.  
    
 
Pre-tax WACC = Debt Weight x Pre-tax Debt Cost 
      + Equity Weight x Pre-tax Equity Cost 
               = 0.3 x [0.048/(1-0.4)] + 0.7 x [0.125/(1-0.4)] 
               = 0.3 x 0.08+ 0.7 x 0.208 
               = 0.17 or 17% 
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In this context, OK Health’s pre-tax cost of debt is 8% (same as coupon rate assuming that bonds 
are trading at par), its pre-tax cost of equity (fund equity) is 20.8%, and its pre-tax cost of capital 
is 17%. With this development, the healthcare provider’s pre-tax EVA is: 
 
   Pre-tax EVA = Pre-tax NOPAT - Pre-tax $WACC 
              = EBIT - Pretax WACC x C 
              = $17,000 - 0.17 x $138,000 
              = $17,000 - $23,460 
               = -$6,460 
 
Not surprisingly, OK Health’s pre-tax EVA is equal to its after-tax EVA grossed up by one 
minus the corporate tax rate, t: 
 
   Pretax EVA = After Tax EVA/(1-t) 
            = -$3,876/(1-0.4) 
            = -$6,460 
 
Role of Capital Efficiency 
It is well known that capital efficiency is essential for creating value within any organization. 
EVA emphasizes capital efficiency through improved working capital management (for 
example, a “just-in-time” inventory system) and/or better utilization of assets including medical 
facilities and technology. To see this, we can express the return on capital as a NOPAT margin 
times a capital turnover ratio: 
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ROC = NOPAT/C 
                     = NOPAT/R x R/C 
                                           =NOPAT/R x R/(NWC+NPPE) 
 
Clearly, anything a manager can do to increase a provider’s net operating margin (NOPAT/Net 
Revenue) will lead to a higher return on capital. Other things the same, anything a manager can 
do to earn more revenue for a given amount of capital--or use less capital (net working capital 
and net plant property and equipment) for a given amount of revenue—will produce a higher 
return on capital. Upon substituting the appropriate ROC figures for OK Health as a Not-for-
Profit provider we obtain: 
 
Pre-tax ROC = EBIT/R x R/C 
=$17,000/$125,000 x $125,000/$138,000 
= 0.136 x 0.91 
= 0.123 or 12.3% 
 
Thus, better capital turns [1/(NWC+NPPE)] at OK Health are needed because its pre-tax cost of 
capital, at 17%, is higher than its pre-tax return on capital. In its status quo position, we see that 
OK Health is hardly “OK” from an EVA perspective, even though its return on capital, at 12.3% 
is positive and seems attractive from a more traditional accounting perspective. 
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Accounting versus EVA 
Break Even Point 
We can also distinguish between the breakeven numbers of patients (units) that a provider would 
need to produce a zero accounting profit versus a value-based measure of breakeven, namely, 
zero economic profit. Specifically, the traditional accounting breakeven point for a provider is 
given by: 
: 
A-BEP = FC/(p-v) 
 
In this expression, FC is fixed costs, which from a managerial accounting perspective includes 
the fixed cost components of COMS and SG&A. In turn, p refers to a composite average price 
charged per patient service and v is the variable cost per patient for medical services supplied. If 
we assume that (1) fixed costs make up 25% of COMS ($86,000) and SG&A ($22,000) 
respectively, (2) the price per unit of patient medical services is $250.00, and (3) variable 
medical costs per patient service is $150.00, then the per-period A-BEP for OK Health is: 
 
A-BEP = 0.25 x $108,000/($250-$150) 
                     =$27,000/100 = 270 patients 
 
From an EVA perspective FC includes accounting fixed costs plus a fixed target dollar return. 
With EVA, the minimum acceptable dollar return to debt holders and fund equity contributors is 
$WACC. Upon substituting OK Health’s pre-tax dollar cost of capital into FC, we obtain the 
break even number of patients in pre-tax EVA terms: 
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E-BEP = ($27,000+$23,460)/($250-$150) 
                = $50460/100 = 505 patients 
 
Thus, a healthcare provider must supply medical services (achieved possibly through 
“outsourcing” medical services) to a larger network with more payer patients in order to 
breakeven in economic profit terms. This is because EVA emphasizes the importance of the cost 
of capital, particularly equity capital in the For-Profit setting and fund equity in a Not-for-Profit 
setting. In the absence of showing a breakeven number of patients in economic terms, a provider 
will have difficulty attracting new capital to invest in the latest medical technology advances. 
Worse yet, an unprofitable provider would be faced with aging facilities falling into disrepair. 
 
OK Health’s Growth Opportunities 
Given that OK Health has negative EVA, it has a clear incentive to find a positive growth 
opportunity. In this context, let’s suppose that the provider discovers that it can invest $20,000 in 
a new medical technology that will increase yearly patient revenue by $40,000. In turn, suppose 
that OK Health’s Cost of Medical Services and Selling, General, and Administrative Expense 
accounts rise by $25,000 and $5,000 per annum, respectively.  With these assumptions, the 
provider’s estimated annual NOPAT will go up by $6,00018: 
 
   ΔNOPAT = Δ[R-COMS-SG&A] x (1-t) 
            = [40,000-25,000-5,000] x (1-0.4) 
            = $6,000 
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 Since OK Health’s operating capital rises by $20,000 to support the higher revenue 
forecast, its estimated (annual) capital costs rise by $2,040: 
 
       Δ$WACC = WACC x ΔC 
            = 0.102 x 20,000 
            = $2,040 
 
Taken together, the changes in NOPAT and $WACC reveal that OK Health’s growth 
opportunity is a desirable investment for its owners.19 With these figures, OK Health’s EVA 
rises by $3,960 per annum: 
 
            ΔEVA = ΔNOPAT - Δ$WACC 
             = $6,000 - $2,040 
             = $3,960 
 
 As a result of OK Health’s medical technology opportunity, we see that the provider has 
moved from a value-destroyer to a value-neutral position. Among other things, this implies that 
the provider’s revised return on capital, 10.3% (16,200/158,000), is now close to the overall cost 
of capital, 10.2%. Likewise, in this value neutral situation, the provider’s residual return on 
capital, RROC, is nearly zero. Of course, with further growth opportunities, OK Health has the 
potential to become a value creator with discounted positive economic profit. Without getting 
into details here, one can also assess the valuation consequences of OK Health’s growth 
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opportunities, including an estimate of its stock price as a For Profit provider or its equivalent 
“shadow” price as a Not-For Profit.20
 
WAYS TO INCREASE EVA 
We now see that EVA is helpful for healthcare providers because it gives a transparent look at 
key features of economic profit measurement. In this context, EVA reveals that a provider is not 
economically profitable until it covers its usual operating expenses and all of its financing 
costs—including the dollar cost of debt and equity (however interpreted). In this sense, EVA is 
superior to accounting profit measures such as operating margins and net income. Additionally, 
we can use basic EVA to gain insight on the financial steps that providers must take to 
permanently improve their economic profit outlook and, thereby, enhance enterprise value. 
 There are several ways that a provider can improve its economic profit outlook.21 
Specifically, the basic EVA formula suggests that value conscious providers should take steps to: 
• Increase net revenue (patients, or otherwise) 
• Reduce operating expenses (COMS and SG&A) where prudent 
• Use less capital to produce the same amount of medical services (improved asset turns) 
• Use more capital to invest in positive growth opportunities (medical facilities, training, 
and community service “investments” that build brand image) 
• Reduce WACC 
 
Expanding a provider’s market share is captured by increasing net revenue in the EVA formula. 
Other things the same (operating expenses and capital costs), higher revenue means higher 
economic profit. Also, it should be no surprise that reducing a provider’s operating expenses via 
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cost cutting and/or achieving tax efficiency enhances economic profit because the COMS, 
SG&A and cash tax accounts go down.22 However, when using cost cutting as a tool to improve 
the EVA outlook, providers must be cautioned that too much cost cutting, “cuts” the fabric of its 
future economic profit, or worse yet, the quality of its medical services. 
 Note that if EVA is to be taken seriously as an improvement over traditional accounting 
profit measures then it must do more than just show that increasing revenue and/or reducing 
operating expenses will improve a provider’s organizational value. Fortunately, this is where 
economic profit and accounting profit measurement depart since EVA fully “accounts” for the 
dollar cost of capital in terms of both the amount of capital employed and the opportunity cost of 
that capital.  
EVA emphasizes the rationalization of capital as can be seen in the basic EVA 
formulation. Clearly, anything that providers can do to (1) improve inventory and net PP&E 
(Plant, Property and Equipment) turnover ratios from the balance sheet, and (2) reduce business 
uncertainty (as manifest in a decline in NOPAT volatility) will have beneficial cost of capital 
implications via the impact on C and WACC, respectively. Moreover, we used the basic EVA 
formula to show that investing more capital (rather than less capital) in positive economic profit 
growth opportunities is really what value creation is all about. 
Also, EVA links the income statement and balance sheets with a value-based focus on net 
operating profit after tax and invested capital. Unlike accounting profit, EVA measures the dollar 
cost of capital by multiplying the amount of capital by the overall cost of capital. Hence, EVA 
measures profit in the classical economists’ notion of “profit” because a providers’ opportunity 
cost of capital is fully reflected in the profit calculation.23 Since accounting profit “accounts” 
only for the dollar cost of debt financing, via interest expense, it completely misses the dollar 
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cost of equity capital. This cost of financing omission is important for providers that finance their 
growth opportunities with (fund) equity—particularly providers that make substantial 
investments in tangibles (medical facilities and technology) and intangibles (net charity care, 
medical training, and community wellness and prevention programs as described below) as well 
as providers that seek to expand their market share in a cost efficient manner. 
 
DISCLOSED EVA 
Before concluding, it is important to understand the role of EVA-based accounting adjustments, 
with an eye toward those adjustments that are unique to healthcare providers. To begin, Bennett 
Stewart provides a “generally accepted” boilerplate of accounting adjustments that are necessary 
to estimate a company’s NOPAT and invested capital24 In this context, Exhibit 4 shows 
traditional accounting adjustments that are used in the equivalent “bottom-up and top-down” 
approaches to estimating a company’s “disclosed” NOPAT, while Exhibit 5 shows capital 
adjustments employed in the “asset and financing” approaches to estimating disclosed capital. 
Additionally, the two exhibits show unique accounting adjustments used in measuring disclosed 
EVA for healthcare providers.  
 
Disclosed NOPAT 
 
In the bottom-up approach to measuring disclosed NOPAT (Exhibit 4 Panel A), the 
provider begins with net operating profit before taxes (using For-Profit terminology). This is just 
operating earnings before interest and taxes (EBIT) on a provider’s income statement.25 To this 
amount, several EVA-based accounting adjustments are made to move toward a better 
representation of the firm’s pre-tax cash operating profit. For examples, the increase in LIFO 
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reserve account is added to operating profit to adjust for the overstatement of cost of goods 
sold—due to overstatement of product costing--in a period of rising prices (inflation), while the 
increase in capitalized research and development (or change in Unamortized R&D account on 
EVA balance sheet) is added back to operating profit to recognize that R&D costs should be 
capitalized (rather than expensed in the year incurred) because they generate a future stream of 
cash flow benefits.26  
 Likewise, the increase in accumulated goodwill amortization (described in footnotes to 
financial statements) is added to operating profit to reflect that goodwill (in the EVA view) is a 
form of capital investment that needs to earn a cost of capital return just like expenditures on 
physical capital. Goodwill intangibles are particularly poignant for healthcare providers like 
hospitals and clinics because expenditures on “charity care” and community wellness and 
prevention programs are key elements to fulfilling the community service mission of both Not-
for-Profit and For Profit providers. Also, Stewart argues that the increase in bad debt reserve 
should be added back to pre-tax operating profit to more accurately reflect a company’s 
experience default rate on consumer receivables. However, since the rise in capitalized net 
charity care is treated separately on the EVA income statement, the change in bad debt reserve 
pertains only to financially able payers that refuse to pay their healthcare obligations. 
Panel A of Exhibit 4 also shows that implied interest expense on operating leases is 
added back to operating results to remove the capital structure effects of debt-related financing 
decisions. Also, the rise in reengineering and/or restructuring costs (write-offs of special items) 
in the typical For Profit setting is added to operating profit as well as the rise in system network 
development costs for multi-hospital providers or like healthcare providers; in the EVA view 
these expenditures are treated as capital “investments.” Moreover, in the case of For-Profit 
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providers (because Not-for-Profits do not usually pay taxes), cash operating taxes, rather than 
reported income taxes, is subtracted from pre-tax operating earnings to arrive at disclosed 
NOPAT. Panel B of Exhibit 4 shows the top-down approach to estimating provider disclosed 
EVA, which should now be self explanatory. 
 
Disclosed Capital 
In the assets approach (Exhibit 5 Panel A) to estimating disclosed capital, the provider begins 
with net short term operating assets (net working capital less short-term debt equivalents). This 
reflects moneys tied up in current assets like accounts receivables and inventories as well as a 
normal amount of cash needed for operations.27 Current liabilities such as accounts payable, 
accrued expenses, and income taxes payable (For-Profit provider) are netted from the short term 
operating asset accounts. Short-term notes payable (a current liability account) are excluded from 
this calculation because they represent a source of debt financing. Interest-bearing debt is 
reflected in the sources of financing approach (Panel B Exhibit 5) to measuring disclosed capital, 
while the debt-interest tax subsidy (For-Profit provider) is reflected in the calculation of a 
company’s dollar cost of capital. 
 Net plant, property, and equipment and goodwill (particularly, acquisition goodwill) are 
then added to net short term operating assets. Special attention should be paid to unamortized 
medical intangibles that are unique to the mission of healthcare providers. These unique “assets” 
include the capitalized (unamortized) values of net charity care, medical training expenditures, 
and community wellness and prevention program costs that are essential to a provider’s 
community service mission.28 Several other “equity equivalents” are added to invested capital; 
these include LIFO Reserve, accumulated goodwill amortization, net capitalized research and 
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development, cumulative bad debt reserve, the cumulative write-off of special items like 
reengineering and restructuring costs, as well as the capitalized value of system-wide 
development and networking costs in multi-hospital settings. Moreover, the present value of 
operating leases (better dubbed leased operating assets) is added back to arrive at disclosed 
capital on the EVA balance sheet. 
 In the sources of financing approach (Exhibit 5 Panel B), the healthcare provider begins 
with Stockholder’s Equity in the For-Profit setting or “Net Assets” in the Not-for-Profit setting. 
To this amount, one adds “equity equivalents” including those already listed on a provider’s 
balance sheet—such as preferred stock, minority interest, and deferred income taxes (For-Profit 
setting)--as well as the companion equity equivalent accounts mentioned above in the equivalent 
assets approach to estimating disclosed capital—namely, traditional equity equivalents including 
LIFO reserve, accumulated goodwill amortization, net capitalized research and development, bad 
debt reserve, and the cumulative write-offs of special items; as well as the capitalized value of 
provider-based intangibles such as net charity care, medical training expenditures, and related 
goodwill.  
In turn, debt and debt equivalents are then added to arrive at disclosed capital in the 
sources of financing approach. These debt-related accounts include those listed on the balance 
sheet--including interest bearing short-term debt, long-term debt, and capitalized lease 
obligations—and “off balance sheet” debts29 such as projected operating lease rentals (typically 
four-to-five year projections) in terms of their present value equivalent. With recognition of 
several EVA-based accounting adjustments, we see that the equivalent asset and financing 
approaches to estimating disclosed capital produce a robust measure (compared with basic EVA 
explained earlier) of economic capital. That being said, a healthcare provider must (still) 
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consistently earn a return on capital that bests the opportunity cost of capital in order to be a 
value creator with discounted positive economic profit. 
  
SUMMARY 
We looked at how to estimate basic economic profit for healthcare providers and we concluded 
with some unique EVA accounting adjustments that result in disclosed EVA; these unique 
accounting adjustments include the capitalized (unamortized) values of net charity care, medical 
training expenditures, and community wellness and prevention program costs that are key to 
fulfilling a provider’s community service mission. We focused initially on basic EVA in order to 
abstract from a myriad of value-based accounting adjustments and instead look at the key 
features of economic profit measurement. We asserted that EVA is consistent with the 
economists’ notion of “profit” because it measures profitability net of both the usual operating 
expenses of running a business (organization) and the opportunity cost of capital. Also, with its 
emphasis on operating profit less capital costs, EVA—more aptly, the discounted value thereof--
is a direct measure of whether or not a healthcare provider is a value creator (discounted positive 
EVA) or a value destroyer.   
Providers should be cautioned that EVA measurement does not imply that accounting 
profit measurement is irrelevant. Indeed, several accounting items such as Net Revenue, COMS, 
and SG&A are included in the estimation of a provider’s NOPAT. Also, accounting profit 
already includes the pre-tax and after-tax interest cost on a provider’s debt. However, this is 
where the similarities between EVA and accounting profit end since EVA links both the income 
statement and balance sheet in a way that fully reflects the dollar cost of all sources of financing, 
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particularly the dollar cost of equity in the For Profit setting and the cost of fund equity in the 
case of Not-For-Profit providers. 
This conceptual difference in profit measurement is poignant for companies (providers or 
otherwise) in sectors like healthcare and (bio) technology that tend to finance their growth 
opportunities with equity rather than debt. For these sectors, the EVA formula can be used to 
show that the weighted average cost of debt and equity, WACC, is in fact the cost of equity. 
Surely, equity (or fund equity) capital is not a “free” source of financing for any provider as 
accounting profit measures such as net operating income (For-Profit and Not-for-Profit settings) 
and earnings per share (For-Profits) might mistakenly suggest.  
 
 27
References 
 
 
Carlson, Jr., Donald A., “Catch the Eye of the Capital Markets,” Healthcare Financial 
Management Magazine (May 2005). 
 
Fama, Eugene F. and Kenneth R. French, “The Cross Section of Expected Stock Returns,” 
Journal of Finance (June 1992). 
 
Gapenski, Louis C., Understanding Healthcare Financial Management (Chicago: 
Health Administration Press, 4th edition, 2003). 
 
Grant, James L., Foundations of Economic Value Added Second Edition (New York: John Wiley 
& Sons, 2003). 
 
Hayden, Eric, “Non-Profit Hospitals Face Structural as Well as Financial Challenges: Lessons 
from Massachusetts”, University of Massachusetts Boston (Working Paper 1003, March 2005). 
 
Health, United States (National Center for Health Statistics, 2002). 
 
Marshall, Alfred, Principles of Economics Volume 1 (New York: MacMillan & Co., 1890), p. 
142. 
 
Partners HealthCare System Inc., Annual Reports (www.partners.org) 
 
Peterson, Pamela, “Value-Based Measures of Performance,” Chapter 4 in Value-Based Metrics: 
Foundations and Practice (Frank J. Fabozzi and James L. Grant (eds.), New York, John Wiley & 
Sons, 2000). 
 
Sharpe, William F., “Capital Asset Prices: A Theory of Market Equilibrium under Conditions of 
Risk,” Journal of Finance (September 1964). 
 
Stewart, G. Bennett III, The Quest for Value (New York: Harper Collins, 1991). 
 
Tully, Shawn, “The Real Key to Creating Value,” Fortune (September 20, 1993). 
 
 
________________________ 
 
 
 
 
 28
Exhibit 1 
OK Health Provider 
Income Statement 
 
   Status Quo 
   Position 
 
Revenue  $125,000 
COMS*      86,000 
Gross Income    $39,000 
SG&A       22,000
Operating Income   $17,000        
Interest Expense       3,312 
Pretax Profit      13,688
Taxes (at 40%)       5,475
Net Income   $   8,213 
 
Shares Outstanding       6,250 
EPS     $   1.31 
 
*COMS=Cost of Medical Services 
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Exhibit 2 
OK Health Provider 
Balance Sheet 
 
 
Cash        7,000   Accounts Payable         10,000 
Securities       8,000   Wages Payable           2,000  
Accounts Receivable      14,000   Tax Accruals            2,000
Inventory     53,000   Current Liabilities         14,000 
Current Assets     82,000    (non-interest bearing) 
        
        
Property       4,000   Long-term Debt          41,400
Net Plant      15,000   (8% Coupon) 
Net Equipment     51,000 
Net Fixed Assets     70,000   Common Stock at Par              625 
       (par value $.10; 6250 
       shares auth./outstanding) 
       Addit. Paid in Capital          14,375  
      Retained Earnings          81,600
       Stockholders’ Equity*          96,600
 
   Liabilities and  
Total Assets   152,000   Stockholders Equity         152,000 
 
 
*As a Not-for-Profit provider, OK-Health’s $96,600 in stockholders’ equity account would 
generally consist of three (rather non-descript) accounts: (1) Un-restricted net assets (in effect, 
retained earnings), (2) temporarily restricted net assets, and (3) permanently restricted net assets.
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Exhibit 3 
OK Health Provider  
Basic Operating and Financial Capital 
(Aggregate Results) 
 
Operating Capital (basic):    Financing Capital (basic): 
 
Net Working Capital 
 Current Assets   82,000   
 Current Liabilities           (14,000) 
 (non-interest bearing)  _____  
     68,000  Long Term Debt   41,400 
 
Net Fixed Assets   70,000  Stockholder’s Equity   96,600
 
  Totals:            138,000     138,000 
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Exhibit 4: Calculation of Provider Disclosed NOPAT  
from Financial Statement Data 
 
Panel A. Bottom-up approach 
Begin: 
Operating profit after depreciation and amortization 
Add: 
Implied interest expense on operating leases 
Increase in LIFO reserve 
Increase in accumulated goodwill amortization 
Increase in capitalized research and development 
Increase in cumulative write-offs of special items 
Increase in bad debt reserve (financially adequate payers) 
Increase in capitalized net charity care 
Increase in capitalized medical training programs 
Increase in capitalized community wellness programs 
Equals: 
Adjusted operating profit before taxes 
Subtract: 
Cash operating taxes 
Equals: 
NOPAT (disclosed) 
 
Panel B. Top-down approach 
Begin: 
Net Sales 
Subtract: 
Cost of goods sold 
Selling, general, and administrative expenses 
Depreciation 
Add: 
Implied interest expense on operating leases 
Increase in equity reserve accounts (see above listing) 
Other operating income 
Equals: 
Adjusted operating profit before taxes 
Subtract: 
Cash operating taxes 
Equals: 
NOPAT (disclosed) 
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Exhibit 5: Calculation of Provider Disclosed Capital  
from Financial Statement Data 
 
Panel A. Assets approach 
Begin: 
Net short-term operating assets* 
Add: 
Net plant, property, and equipment 
Other assets 
Goodwill (acquisitions) 
LIFO reserve 
Accumulated goodwill amortization 
Capitalized research and development 
Cumulative write-offs of special items 
Bad-debt reserve (financially adequate payers) 
Capitalized net charity care 
Capitalized medical training programs 
Capitalized community wellness programs 
Present value of operating leases 
Equals: 
Capital (disclosed) 
 
Panel B. Sources of financing approach 
Begin: 
Book value of common equity 
Add equity equivalents: 
Preferred stock 
Minority interest 
Deferred income tax 
Equity reserve accounts (see above listing) 
Add debt and debt equivalents: 
Interest bearing short-term debt 
Current portion of long-term debt due 
Long-term debt 
Capitalized lease obligations 
Present value of operating leases 
Equals: 
Capital (disclosed) 
 
*Net short-term operating assets = Current Assets less Current Liabilities (excluding debt-related 
short-term liabilities) 
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1 EVA® is a registered trademark of Stern Stewart & Co. While this primer emphasizes the role of economic profit 
(EVA) in creating value, the methodology could be used as part of a more general “balanced scorecard” approach, 
with EVA analyses substituting for more traditional ways (margins, ROI, ROE) of measuring provider financial 
performance. 
2 For example, as of 2002, Not-for-Profit (and voluntary) hospitals accounted for some 61% of community hospitals 
in the United States. For-Profit or investor owned hospitals made up about 15% of the total while state and local 
government community hospitals, at 24% accounted for the balance (Health, United States, 2002, p. 279). 
3 See Stewart (1991). 
4 In principle, charity care costs can be viewed as an intangible asset that is central to the community service mission 
of healthcare providers, particularly hospitals and clinics. The phrase “net charity care” is used to recognize that this 
intangible arises from voluntary expenditures made by providers over-and -above required contributions to a state 
uncompensated care pool or those made simply to preserve the tax-exempt status of a Not-for-Profit provider. 
Hence, net (or excess) charity care is a truly voluntary contribution that enhances one’s brand image. Moreover, 
providers should distinguish between net charity care and bad debt expense, where in the latter case an individual is 
deemed financially able to pay, yet unwilling to do so. We’ll say more on charity care and related intangibles such 
as community wellness and prevention program costs at a later point. 
5 Unlike For-Profit providers, the concept of “equity” for a Not-for-Profit provider is rather vague. Conventional 
accounting uses the term “net assets” on the balance sheet of Not-for-Profit providers to represent the difference 
between assets and liabilities. In the For-Profit case, the difference between asset and liability accounts is the 
familiar Stockholders’ Equity account. Moreover, the net asset account for Not-for-Profits can be separated into 
three other non-descript labels: unrestricted net assets (in effect, retained earnings), temporarily restricted net assets, 
and permanently restricted net assets.  See, for example, Partners HealthCare annual reports at www.partners.org. 
   In this EVA primer, we’ll use the term “fund equity” to represent the overall net asset account of Not-for-Profit 
providers. This terminology makes a connection with the For-Profit concept of equity in that donors have 
contributed risk capital to providers. In turn, risk capital has an opportunity cost (or required return) just like equity 
capital in the For-Profit setting. This reflects equity capital costs on both donor contributions to providers and the 
buildup (or builddown in the event of losses) of retained earnings in the unrestricted net asset account. 
6 For a complete discussion of EVA, see Grant (2003). 
7 In effect, “t” is an unlevered tax rate because EVA equals NOPAT less cash taxes free of any debt tax subsidies.  
This is relevant for For-Profit providers. 
8 This section draws on EVA application from Grant (2003); recast with application to For-Profit and Not-for-Profit 
healthcare providers. 
9 The assumed margins are actually higher than the 3-4% median margins observed for hospitals over the 1998 to 
2003 period. For example, median operating margins for Massachusetts hospitals range from about -1% to 0% 
during this six-year period. See Hayden (2005). 
10 For analysis of healthcare providers using traditional metrics, such as operating margins, turnover ratios, and rate 
of return metrics (ROA, ROI, and ROE), see Gapenski (2003). See also Carlson (2005) for recent insights on how to 
use balance sheet management and structured (tax-exempt) debt products as a way of enhancing the visibility of 
providers to investors. In this EVA primer for healthcare providers, we emphasize a value proposition for enticing 
investors via positive economic earnings as reflected in the difference between a provider’s operating earnings and 
its dollar cost of capital (or positive spread between return on capital and cost of capital). 
11 For convenience, we’ll assume that depreciation on medical facilities and equipment is included in the SG&A 
account. Without getting into EVA details, one could also distinguish between accounting depreciation and 
economic depreciation.  
12 We’ll discuss how to calculate the cost of capital for a Not-for-Profit provider following our discussion of a For-
Profit. By their namesake, Not-for-Profits do not pay taxes (strictly speaking) so there are no tax subsidies arising 
from asset depreciation and interest expense on debt financing. However, the cost of equity, more aptly, “fund 
equity” needs to be grossed up by (1-t). 
13 See Sharpe (1964). Also, the “just right” way of calculating a company’s cost of equity has come under several 
empirical challenges. For example, see Fama and French (1992). However, it should be noted that the validity of the 
EVA model does not require that asset prices are set according to the single (beta)-factor CAPM. 
14 The cost of equity for a Not-for-Profit provider, referred to as “fund” equity, deserves special attention which 
we’ll discuss in a later section. 
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15 Persistently negative EVA leads to negative NPV (value destruction). 
16 The spread between ROC and WACC is commonly referred to as the “EVA spread.” If goodwill (arising from 
premiums paid in corporate acquisitions under purchase accounting) is listed on a provider’s balance sheet, then one 
can distinguish between the operating return on capital and the total return on capital. As Peterson emphasizes 
(2000), the appropriate capital return measure depends on whether managers are interested in measuring the firm’s 
operating efficiency-which calls for using the former profit ratio-or the efficiency of management in using total 
capital-given perhaps an acquisitions strategy which would call for using the latter ratio. Also, which capital 
measure to use is poignant for healthcare providers if one treats charity care and related medical intangibles as key 
to fulfilling a community service mission. 
17 As noted before, the difference between assets and liabilities for Not-for-Profit providers is often called “net 
assets.” We’ll replace this rather non-descript terminology with the words “fund equity” for reasons cited before. 
18 The growth opportunity figures are expressed for OK Health as a For Profit provider. To obtain the corresponding 
change in EVA for a Not-for-Profit, simply “gross up” (or divide) the after-tax change in EVA by (1-t). 
19 This applies to OK Health as a For Profit provider. As a Not-for Profit provider, we interpret equity contributors 
(grantors and donors) as fund equity holders (investors). 
20 See Grant (2003). 
21 The first four ways of improving EVA are consistent with those mentioned by Tully (1993). 
22 The positive impact of tax efficiency applies only in the For-Profit setting. 
23 Alfred Marshall (1890, p. 142) is often cited for the economist’s notion that “profit” should be reflect opportunity 
costs (and benefits). 
24 Stewart (1991). 
25 Net operating profit before taxes (EBIT) is also the same as operating profit after depreciation and amortization. 
26 In other words, R&D expenditures should be capitalized and amortized over a useful time period such as five 
years—rather than expensed in the current year as if these expenditures have no future cash flow benefits. For 
example, if R&D expenditures for a given year were $100,000, then $80,000 would be placed on the EVA balance 
sheet (at year end) and the remaining $20,000 would be charged to income. Assuming the entire R&D investment 
were already included in a Selling, General and Administrative expenses account, then the net R&D increase of 
$80,000 would get added back to obtain the EVA amortization of R&D expenditures, at $20,000. A similar EVA 
treatment would apply to medical intangibles, unique to healthcare providers. 
27 The normal amount of cash required for operations varies by industry—say 0.5% to 2% of net sales. As noted 
before, one can make a distinction between total invested capital and operating capital. Operating capital is generally 
viewed as invested capital net of excess cash and marketable securities and goodwill-related accounts. In principle, 
excess cash could be used to pay down debt; in that event, EVA debt would be interpreted as net debt. 
28 In practice, it may be better to list the capitalized value of net charity care and like expenditures that are part of a 
provider’s mission as “equity equivalents” (mentioned next). 
29 The EVA recognition of “off balance sheet” debt brings up an interesting issue. While EVA accounting uses 
information that is deemed accurate from a company’s published financial reports—including income statement, 
balance sheet, and relevant footnotes, EVA like accounting profit cannot possibly reflect “off balance sheet” debts 
arising from hidden liabilities or fraudulent accounting transactions as in the notorious case of Enron. 
